Urokinase-type plasminogen activator (uPA) and its receptor, uPAR, are important components of cell surface proteolysis used by tumour cells and capillary endothelial cells, and therefore play crucial roles in the establishment, metastasis and angiogenesis of most solid tumours [2,3]. This evidence concerns the gene PLAU and neoplasm.